以色列 - 英文 - Ministry of Health

perrigo israel agencies ltd, israel - bismuth sub salicylate - suspension - bismuth sub salicylate 262.50 mg / 15 ml - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

爱尔兰 - 英文 - HPRA (Health Products Regulatory Authority)

mcneil healthcare (ireland) ltd - bismuth subgallate, bismuth oxide, balsam peru, zinc oxide - ointment - other agents for treatment of hemorrhoids and anal fissures for topical use

美国 - 英文 - NLM (National Library of Medicine)

ailex pharmaceuticals, llc - bismuth subsalicylate (unii: 62tey51rr1) (salicylic acid - unii:o414pz4lpz) - the components of bismuth subsalicylate chewable tablets/ metronidazole tablets/tetracycline hydrochloride capsules (bismuth subsalicylate, metronidazole, and tetracycline hydrochloride), in combination with an h2 antagonist, are indicated for the eradication of h. pylori for treatment of patients with h. pylori infection and duodenal ulcer disease (active or a history of duodenal ulcer). the eradication of h. pylori has been demonstrated to reduce the risk of duodenal ulcer recurrence in patients with active duodenal ulcer disease (see clinical studies and dosage and administration ). to reduce the development of drug-resistant bacteria and maintain the effectiveness of bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules and other antibacterial drugs, bismuth subsalicylate chewable tablets/metronidazole tablets/tetracycline hydrochloride capsules should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptib

以色列 - 英文 - Ministry of Health

teva israel ltd - benzocaine; bismuth oxychloride; menthol; thymol biiodide; zinc oxide - ointment - zinc oxide 10 %w/w; benzocaine 4 %w/w; menthol 0.25 %w/w; bismuth oxychloride 8 %w/w; thymol biiodide 2 %w/w - bismuth preparations, combinations - bismuth preparations, combinations - symptomatic relief of pain and discomfort in irritated anorectal tissues in: hemorrhoids, proctitis, papillitis, cryptitis, fissures and following anorectal surgery.

加拿大 - 英文 - Health Canada

laboratoires juvise pharmaceuticals - bismuth oxide (bismuth subcitrate potassium); tetracycline hydrochloride; metronidazole - capsule - 40mg; 125mg; 125mg - bismuth oxide (bismuth subcitrate potassium) 40mg; tetracycline hydrochloride 125mg; metronidazole 125mg - tetracyclines

澳大利亚 - 英文 - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - bismuth subsalicylate - oral solution/suspension - bismuth subsalicylate mineral-bismuth active 17.5 mg/ml - alimentary system - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - diarrhoea | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

美国 - 英文 - NLM (National Library of Medicine)

physicians total care, inc. - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth - unii:u015tt5i8h), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - bismuth subcitrate potassium 140 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs, pylera should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. pylera in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. do not administer methoxyflurane to patients taking pylera. the concurrent use of tetracycline hydrochloride, a component of pylera, with methoxyflurane has been reported to resu

英国 - 英文 - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - bismuth subnitrate; iodoform - cutaneous paste - 252mg/1gram ; 503mg/1gram

加拿大 - 英文 - Health Canada

dolisos laboratoires s.a. - bismuth - tablet - 4ch - bismuth 4ch - homeopathic products

加拿大 - 英文 - Health Canada

dolisos laboratoires s.a. - bismuth - drops - 8x - bismuth 8x - homeopathic products